Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...

Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, a study shows.

People who develop MS begin using healthcare services more frequently up to 15 years before their MS symptoms first appear.

PET imaging using a novel tracer may help identify nerve damage in MS that can't be identified with conventional MRI imaging, ...

The experimental CAR T-cell therapy treatment was given as part of a clinical trial that's enrolling adults with progressive ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow ...

Columnist Ben Hofmeister says he makes sure to ask questions in a healthcare setting because his experience as a patient is important.

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...